Publications by authors named "Tim Dudderidge"

Claim this Profile
P
Patients' Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER Study.
Martin J Connor, Mesfin Genie, Tim Dudderidge, Hangjian Wu, Johanna Sukumar

Eur Urol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Analysis of Prostate Cancer Care Using a Biomarker-enhanced Diagnostic Strategy with Stockholm3.
Olga Dianna McLeod, Thorgerdur Palsdottir, Jochen Walz, Derya Tilki, Alberto Briganti, Tim Dudderidge

Eur Urol Open Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal therapy for prostate cancer - when to refer?
Nadia Rokan, Deepika Reddy, Tim Dudderidge

BJU Int· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and International Consensus Recommendations.
Alexander Light, Nikhil Mayor, Emma Cullen, Alex Kirkham, Anwar R Padhani, Tim Dudderidge

Eur Urol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial.
Alexander Light, Abi Kanthabalan, Marjorie Otieno, Menelaos Pavlou, Rumana Omar, Tim Dudderidge

Eur Urol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of a risk model predicting failure of salvage focal ablation for prostate cancer.
Alexander Light, Max Peters, Deepika Reddy, Abi Kanthabalan, Marjorie Otieno, Tim Dudderidge

BJU Int· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis.
Deepika Reddy, Marieke van Son, Max Peters, Mariana Bertoncelli Tanaka, Tim Dudderidge

J Med Econ· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year Experience.
David Habashy, Deepika Reddy, Max Peters, Taimur T Shah, Marieke van Son, Tim Dudderidge

J Urol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Landmarks in the evolution of prostate biopsy.
Martin J Connor, Michael A Gorin, David Eldred-Evans, Edward J Bass, Ankit Desai, Tim Dudderidge

Nat Rev Urol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Magnetic Resonance Imaging and targeted biopsies compared to transperineal mapping biopsies prior to salvage focal therapy/ablation in localised and metastatic recurrent prostate cancer after radiotherapy. Primary Outcomes from the FORECAST Trial" [Eur Urol 2022;81(6):598-605].
Taimur T Shah, Abi Kanthabalan, Marjorie Otieno, Menelaos Pavlou, Rumana Omar, Tim Dudderidge

Eur Urol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing the Frequency of Follow-up Cystoscopy in Low-grade pTa Non-muscle-invasive Bladder Cancer Using the ADXBLADDER Biomarker.
Morgan Rouprêt, Paolo Gontero, Stuart R C McCracken, Tim Dudderidge, Jacqueline Stockley

Eur Urol Focus· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After Radiotherapy.
Taimur T Shah, Abi Kanthabalan, Marjorie Otieno, Menelaos Pavlou, Rumana Omar, Tim Dudderidge

Eur Urol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience.
Deepika Reddy, Max Peters, Taimur T Shah, Marieke van Son, Mariana Bertoncelli Tanaka, Tim Dudderidge

Eur Urol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Review of Patients' Values, Preferences, and Expectations for the Treatment of Metastatic Prostate Cancer.
Martin J Connor, Mesfin G Genie, David Burns, Edward J Bass, Michael Gonzalez, Tim Dudderidge

Eur Urol Open Sci· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour control.
Marieke J van Son, Max Peters, Deepika Reddy, Taimur T Shah, Feargus Hosking-Jervis, Tim Dudderidge

Prostate Cancer Prostatic Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.
Elizabeth K Bancroft, Elizabeth C Page, Mark N Brook, Sarah Thomas, Natalie Taylor, Tim Dudderidge

Lancet Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic prostate cancer men's attitudes towards treatment of the local tumour and metastasis evaluative research (IP5-MATTER): protocol for a prospective, multicentre discrete choice experiment study.
Martin John Connor, Mesfin G Genie, Michael Gonzalez, Naveed Sarwar, Kamalram Thippu Jayaprakash, Tim Dudderidge

BMJ Open· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiparametric magnetic resonance imaging - a crucial imaging tool for considering and planning prostate cancer focal therapy.
Tim J Dudderidge

BJU Int· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of Comparative Health Research Outcome of Novel Surgery in prostate cancer (IP4-CHRONOS): statistical analysis plan for the randomised feasibility phase of the CHRONOS study.
Emily Day, A Toby Prevost, Matthew R Sydes, Deepika Reddy, Taimur T Shah, Tim Dudderidge

Trials· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study.
Taimur T Shah, Deepika Reddy, Max Peters, Daniel Ball, Na Hyun Kim, Tim Dudderidge

Prostate Cancer Prostatic Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal HIFU therapy for anterior compared to posterior prostate cancer lesions.
Philipp M Huber, Naveed Afzal, Manit Arya, Silvan Boxler, Tim Dudderidge

World J Urol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the performances of the ADXBLADDER test and urinary cytology in the follow-up of non-muscle-invasive bladder cancer: a blinded prospective multicentric study.
Paulo Gontero, Emanuele Montanari, Morgan Roupret, Fabrizio Longo, Jacqueline Stockley, Tim Dudderidge

BJU Int· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trial.
Martin John Connor, Taimur Tariq Shah, Katarzyna Smigielska, Emily Day, Johanna Sukumar, Tim Dudderidge

BMJ Open· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists.
Lina Maria Carmona Echeverria, Aiman Haider, Alex Freeman, Urszula Stopka-Farooqui, Avi Rosenfeld, Tim Dudderidge

Sci Rep· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal therapy, time to join the multi-disciplinary team discussion?
Deepika Reddy, Nishant Bedi, Tim Dudderidge

Transl Androl Urol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis